Mahana Therapeutics Revenue and Competitors

Location

$81.6M

Total Funding

Estimated Revenue & Valuation

  • Mahana Therapeutics's estimated annual revenue is currently $6.1M per year.(i)
  • Mahana Therapeutics's estimated revenue per employee is $125,500
  • Mahana Therapeutics's total funding is $81.6M.

Employee Data

  • Mahana Therapeutics has 49 Employees.(i)
  • Mahana Therapeutics grew their employee count by -27% last year.

Mahana Therapeutics's People

NameTitleEmail/Phone
1
CEO & co-founderReveal Email/Phone
2
VP, Regulatory Affairs & Quality AssuranceReveal Email/Phone
3
Associate Director, Clinical DevelopmentReveal Email/Phone
4
Associate Director Talent & CultureReveal Email/Phone
5
Staff Software EngineerReveal Email/Phone
6
Board Observer / Advisor / Fractional CPOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Mahana Therapeutics?

Mahana Therapeutics is a global leader in prescription digital therapeutics for chronic conditions. Guided by a commitment to rigorous clinical evidence and drawn from experience as patients ourselves, Mahana’s team of experienced entrepreneurs, physicians, psychologists, engineers, and designers is dedicated to developing software to treat and manage chronic conditions that affect so many. Founded in 2018, Mahana is located in San Francisco and London. For more information, visit www.mahanatx.com or follow us @mahanatx. We’re hiring! Mahana is actively accepting applications from candidates across the country to join our growing virtual team.

keywords:N/A

$81.6M

Total Funding

49

Number of Employees

$6.1M

Revenue (est)

-27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Mahana Therapeutics News

2022-04-13 - Gut-Brain Connect: metaMe's Digital Therapeutic Hopes To ...

metaMe CEO Rudolphi also sought to differentiate Regulora from Mahana Therapeutics' on-market, FDA authorized PDT, Parallel, used to reduce...

2021-08-11 - Mahana Therapeutics Raises $61M in Series B Financing

Mahana Therapeutics, a San Francisco, CA-based developer of prescription digital therapeutics designed to empower patients with chronic health conditions, raised $61m in Series B financing. The round was led by JAZZ Venture Partners and Gurnet Point Capital with participation from new and exist ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.4M490%N/A
#2
$10.1M490%$175.5M
#3
$8M49N/AN/A
#4
$5.4M490%$602.6M
#5
$5.4M4969%$23.6M